"Homozygote" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An individual in which both alleles at a given locus are identical.
| Descriptor ID |
D006720
|
| MeSH Number(s) |
G05.380.554
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Homozygote".
Below are MeSH descriptors whose meaning is more specific than "Homozygote".
This graph shows the total number of publications written about "Homozygote" by people in this website by year, and whether "Homozygote" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 6 | 6 |
| 1998 | 1 | 5 | 6 |
| 1999 | 0 | 5 | 5 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 11 | 11 |
| 2002 | 1 | 6 | 7 |
| 2003 | 1 | 11 | 12 |
| 2004 | 0 | 8 | 8 |
| 2005 | 0 | 9 | 9 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 8 | 9 |
| 2008 | 2 | 9 | 11 |
| 2009 | 0 | 13 | 13 |
| 2010 | 1 | 11 | 12 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 13 | 13 |
| 2013 | 1 | 9 | 10 |
| 2014 | 1 | 6 | 7 |
| 2015 | 5 | 8 | 13 |
| 2016 | 1 | 12 | 13 |
| 2017 | 2 | 11 | 13 |
| 2018 | 4 | 14 | 18 |
| 2019 | 2 | 15 | 17 |
| 2020 | 2 | 11 | 13 |
| 2021 | 2 | 11 | 13 |
| 2022 | 0 | 7 | 7 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 6 | 8 |
| 2025 | 1 | 3 | 4 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Homozygote" by people in Profiles.
-
The biomedical landscape of genomic structural variation in the qatari population. Nat Commun. 2026 Jan 13; 17(1):1019.
-
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 2026 Feb; 14(2):123-136.
-
A novel homozygous frameshift mutation likely causing nonsense-mediated mRNA decay in an Algerian kindred with CD19 complex deficiency. Front Immunol. 2025; 16:1634146.
-
Simulation model to estimate pretreatment (baseline) low-density lipoprotein cholesterol levels in people living with homozygous familial hypercholesterolemia. J Clin Lipidol. 2025 Sep-Oct; 19(5):1457-1462.
-
A Maternal Loss-of-Function Variant in KHDC3L Gene Causes a Range of Adverse Pregnancy Outcomes: A Case Report. Mol Genet Genomic Med. 2025 Jan; 13(1):e70051.
-
Ataxia With Vitamin E Deficiency: Case Series, Vitamin E Therapy Response, Founder Effect, and In Silico Analysis. Clin Genet. 2025 Mar; 107(3):366-368.
-
Homozygous variants in WDR83OS lead to a neurodevelopmental disorder with hypercholanemia. Am J Hum Genet. 2024 Nov 07; 111(11):2566-2581.
-
Recessive loss-of-function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine-Lubinsky syndrome. Am J Med Genet A. 2025 Jan; 197(1):e63845.
-
It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States. Glob Heart. 2024; 19(1):43.
-
Multilocus pathogenic variants contribute to intrafamilial clinical heterogeneity: a retrospective study of sibling pairs with neurodevelopmental disorders. BMC Med Genomics. 2024 04 16; 17(1):85.